Palisade Bio to Participate in Upcoming Investor Conferences

Palisade Bio plans multiple September 2026 investor presentations, with live webcasts and replays available through its investor relations website.

Rhea-AI Summary

Palisade Bio (PALI) will participate in three healthcare investor conferences in September 2026, including events hosted by Wells Fargo, Morgan Stanley and H.C. Wainwright.

The Morgan Stanley fireside chat is on September 16, 2026, 10:00–10:35 AM ET in New York. The H.C. Wainwright presentation is on September 16, 2026, 3:00–3:30 PM ET in New York. Live webcasts and limited-time replays will be available on the Investors section of palisadebio.com.

AI-generated analysis. How Rhea-AI works. Not financial advice.

See more from StockTitan in Google Search and AI answers. Adds StockTitan as a preferred source · opens Google

Add on Google Not now

Denver, CO, Sept. 03, 2026 (GLOBE NEWSWIRE) -- Palisade Bio, Inc. (Nasdaq: PALI) (“Palisade” or the “Company”), a clinical-stage biopharmaceutical company developing next-generation prodrugs for patients living with inflammatory and fibrotic diseases, today announced that members of management will participate in three healthcare investor conferences in September 2026.

Wells Fargo 2026 Healthcare Conference

Dates: September 8–10, 2026
Location: Boston, Massachusetts
Format: Investor meetings

Morgan Stanley 24th Annual Global Healthcare Conference

Dates: September 14–16, 2026
Location: New York, New York
Fireside Chat: Wednesday, September 16, 2026, from 10:00–10:35 AM ET
Format: In-person fireside chat and investor meetings
Webcast Registration

H.C. Wainwright 28th Annual Global Investment Conference

Dates: September 14–16, 2026
Location: New York, NY
Presentation: Wednesday, September 16, 2026, from 3:00–3:30 PM ET
Presentation Location: Kennedy II, 4th Floor
Format: In-person fireside chat and investor meetings
Webcast Registration

Investors interested in meeting with Palisade Bio management during the conferences should contact their respective conference representatives.

Live webcasts of the fireside chats will be accessible on the Events page in the Investors section of the Company’s website at palisadebio.com. Replays will be available following the live events and will be archived for a limited time.

About Palisade Bio

Palisade Bio, Inc. (Nasdaq: PALI) is a clinical-stage biopharmaceutical company developing prodrugs for patients living with inflammatory and fibrotic diseases.

The Company’s lead clinical product candidate, PALI-2108, is being advanced into Phase 2 clinical trials as a treatment for patients living with inflammatory bowel disease (IBD), including ulcerative colitis (UC) and Crohn’s disease (CD). Despite the availability of multiple biologic and small-molecule therapies, many patients with UC and CD do not achieve durable remission, lose response over time, or discontinue treatment because of safety or tolerability limitations. The Company believes PALI-2108 has the potential to address these limitations through once-daily oral dosing, targeted lower-intestinal bioactivation and broad PDE4-mediated anti-inflammatory activity.

For more information, please go to www.palisadebio.com.

Investor Relations Contact

JTC Team, LLC
Jenene Thomas
908-824-0775
PALI@jtcir.com 

FAQ

Which investor conferences will Palisade Bio (PALI) attend in September 2026?

Palisade Bio will join three events in September 2026: the Wells Fargo 2026 Healthcare Conference, the Morgan Stanley 24th Annual Global Healthcare Conference, and the H.C. Wainwright 28th Annual Global Investment Conference.

When and where is Palisade Bio presenting at the Morgan Stanley healthcare conference 2026 (PALI)?

At the Morgan Stanley 24th Annual Global Healthcare Conference in New York, NY, Palisade Bio will hold an in-person fireside chat on Wednesday, September 16, 2026, from 10:00–10:35 AM ET, along with investor meetings.

What is the schedule for Palisade Bio at the H.C. Wainwright 28th Annual Global Investment Conference (PALI)?

At the H.C. Wainwright 28th Annual Global Investment Conference in New York, NY, Palisade Bio is scheduled for a presentation on Wednesday, September 16, 2026, from 3:00–3:30 PM ET in Kennedy II, 4th Floor, with in-person investor meetings.

How can investors access the Palisade Bio (PALI) webcasts for the September 2026 conferences?

Live webcasts of Palisade Bio’s September 2026 fireside chats and presentations will be accessible on the Events page in the Investors section of palisadebio.com. Replays will be available after the events and archived for a limited time.

How can investors arrange meetings with Palisade Bio management during the September 2026 conferences (PALI)?

Investors who want to meet with Palisade Bio management during the September 2026 conferences should contact their respective conference representatives to request and schedule investor meetings.